Ethicon Suspends Minimally Invasive Uterine Surgery Equipment
While Ethicon's devices for the procedure have included a warning about the spread of cancerous cells, it has decided to suspend the devices until such time as the FDA clearly defines the risks associated with morcellation, according to the report.
"At Ethicon, our first priority is to our customers and patients," a company spokesman told the Enquirer.
More Articles on Quality:
5 Tips for Focusing Infection Control Policies
10 Things to Know About Infection Control
ASCA Encourages AHRQ ASC Patient Safety Program Participation
© Copyright ASC COMMUNICATIONS 2015. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
New From Becker's Infection Control & Clinical Quality
11 expert recommendations for C. Diff-associated diarrhea preventionRead Now
- EHRs in ASCs: 5 thoughts for the present and future
- Seattle hospitals receive low infection control rating — ASCs maintain low risk
- 6 notes on primary care physicians' outlook on healthcare technology
- Dignity Health Saint Francis Memorial Hospital opens Orthopedic Institute — 6 things to know
- 'Probable' West Nile case in Ohio — 5 notes